dc.contributor.author | Bailey, Justin | eng |
dc.contributor.author | Carter, Nakia Joyce | eng |
dc.date.issued | 2009 | eng |
dc.description.abstract | Probiotics and rifaximin (Xifaxan) have been shown to reduce total number of flatus episodes and associated discomfort. (Strength of Recommendation [SOR]: B, based on small randomized controlled trials [RCTs]). Oral alpha-galactosidase (Beano) has been shown to reduce volume of flatus associated with fermentable carbohydrates and high-fiber diets. (SOR: B, based on small RCTs). Oral bismuth subsalicylate (Pepto-Bismol) and odor-reducing external devices containing activated charcoal have shown benefit in reducing flatus-associated odor. (SOR: C, based on disease-oriented evidence). Evidence for oral activated charcoal and simethicone has been inconsistent and does not support their use. (SOR: B, based on multiple small RCTs). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3874 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2009 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | American family physician, 79, no. 12 (June 2009): 1098+. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | flatus | eng |
dc.subject | probiotics | eng |
dc.subject | odor reduction | eng |
dc.subject.lcsh | Flatulence -- Treatment | eng |
dc.subject.lcsh | Carbon, Activated -- Therapeutic use | eng |
dc.subject.lcsh | Probiotics -- Therapeutic use | eng |
dc.title | Effective Management of Flatulence | eng |
dc.type | Article | eng |